By Connor Hart Mattel is partnering with OpenAI to develop AI-powered toys and experiences around its portfolio of brands.

Mattel MAT.O has teamed up with OpenAI to develop toys and games with artificial intelligence, and expects to launch its first AI-powered product later this year, the Barbie-maker said on Thursday.

Sanofi has agreed to acquire US-based Blueprint Medicines for an equity value of $9.1bn to bolster its immunology pipeline with rare disease treatments.

Reports revealed that AI rivals Google and OpenAI struck a deal to provide OpenAI with Google’s cloud computing services.

Executives at OpenAI have discussed accusing the company’s major backer, Microsoft, of anticompetitive behavior, the Wall Street Journal reported.

Barbie's going AI. Mattel, the company behind Barbie and Hot Wheels, is teaming up with OpenAI to build AI-powered toys.

Mattel has teamed up with OpenAI to develop toys and games with artificial intelligence, and expects to launch its first AI-powered product later this year, the Barbie-maker said on Thursday.

Barbie maker Mattel is partnering with OpenAI to develop generative AI-powered toys and games, as the new technology disrupts a wide range of industries, Mattel announced Thursday.

(Reuters) -OpenAI said on Wednesday it had not partnered with Robinhood for the stock tokens the trading platform unveiled earlier this week.

The AI startup’s biggest clients, which include OpenAI and Google, won’t likely want to trust their data to a company almost half owned by Mark Zuckerberg’s tech empire.

Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.